Cargando…

Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis

BACKGROUND: MicroRNAs (miRNAs) negatively regulate the 3′ untranslated region (3′-UTR) of coding genes by suppressing translation or degrading mRNAs, and they act as oncogenes or tumor suppressors. Recently, several studies investigated the association between pre-miR-27a rs895819 polymorphism and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Qian, He, Cai-yun, Liu, Jing-wei, Yuan, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676439/
https://www.ncbi.nlm.nih.gov/pubmed/23762318
http://dx.doi.org/10.1371/journal.pone.0065208
_version_ 1782272640354877440
author Xu, Qian
He, Cai-yun
Liu, Jing-wei
Yuan, Yuan
author_facet Xu, Qian
He, Cai-yun
Liu, Jing-wei
Yuan, Yuan
author_sort Xu, Qian
collection PubMed
description BACKGROUND: MicroRNAs (miRNAs) negatively regulate the 3′ untranslated region (3′-UTR) of coding genes by suppressing translation or degrading mRNAs, and they act as oncogenes or tumor suppressors. Recently, several studies investigated the association between pre-miR-27a rs895819 polymorphism and the risks of various cancers, but the results were inconsistent. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a meta-analysis of 13 studies that included 6501 cancer cases and 7571 controls to address this association. Overall, this meta-analysis showed that the pre-miR-27a rs895819 A/G polymorphism was not statistically associated with cancers risk in all genetic models. In the stratified analysis by cancer types, when compared with the ancestral A allele, individuals with the variant G allele was consistently associated with reduced risks of breast cancer (OR = 0.92, 95% CI = 0.85–0.99), renal cell cancer (OR = 0.81, 95% CI = 0.67–0.97) and nasopharyngeal cancer (OR = 0.84, 95% CI = 0.72–0.97). Inversely, individuals with the heterozygote AG was associated with an increased risk of digestive tract cancers compared with AA genotype (AG vs. AA: OR = 1.16, 95% CI = 1.01–1.32). In the stratified analysis by ethnicity, the pre-miR-27a rs895819 polymorphism showed statistically significant association with decreased risks of cancers in Caucasians (G vs. A allele: OR = 0.90, 95% CI = 0.83–0.97; AG vs. AA: OR = 0.84, 95% CI = 0.75–0.94; AG/GG vs. AA: OR = 0.85, 95% CI = 0.76–0.94) but not in Asians. CONCLUSION/SIGNIFICANCE: This meta-analysis suggests that the pre-miR-27a rs895819 polymorphism may contribute to the susceptibilities of some specific-type of cancers, including breast cancer, renal cell cancer, nasopharyngeal cancer and digestive tract cancers, as well as the susceptibilities of cancers in Caucasians to some extent.
format Online
Article
Text
id pubmed-3676439
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-36764392013-06-12 Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis Xu, Qian He, Cai-yun Liu, Jing-wei Yuan, Yuan PLoS One Research Article BACKGROUND: MicroRNAs (miRNAs) negatively regulate the 3′ untranslated region (3′-UTR) of coding genes by suppressing translation or degrading mRNAs, and they act as oncogenes or tumor suppressors. Recently, several studies investigated the association between pre-miR-27a rs895819 polymorphism and the risks of various cancers, but the results were inconsistent. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a meta-analysis of 13 studies that included 6501 cancer cases and 7571 controls to address this association. Overall, this meta-analysis showed that the pre-miR-27a rs895819 A/G polymorphism was not statistically associated with cancers risk in all genetic models. In the stratified analysis by cancer types, when compared with the ancestral A allele, individuals with the variant G allele was consistently associated with reduced risks of breast cancer (OR = 0.92, 95% CI = 0.85–0.99), renal cell cancer (OR = 0.81, 95% CI = 0.67–0.97) and nasopharyngeal cancer (OR = 0.84, 95% CI = 0.72–0.97). Inversely, individuals with the heterozygote AG was associated with an increased risk of digestive tract cancers compared with AA genotype (AG vs. AA: OR = 1.16, 95% CI = 1.01–1.32). In the stratified analysis by ethnicity, the pre-miR-27a rs895819 polymorphism showed statistically significant association with decreased risks of cancers in Caucasians (G vs. A allele: OR = 0.90, 95% CI = 0.83–0.97; AG vs. AA: OR = 0.84, 95% CI = 0.75–0.94; AG/GG vs. AA: OR = 0.85, 95% CI = 0.76–0.94) but not in Asians. CONCLUSION/SIGNIFICANCE: This meta-analysis suggests that the pre-miR-27a rs895819 polymorphism may contribute to the susceptibilities of some specific-type of cancers, including breast cancer, renal cell cancer, nasopharyngeal cancer and digestive tract cancers, as well as the susceptibilities of cancers in Caucasians to some extent. Public Library of Science 2013-06-07 /pmc/articles/PMC3676439/ /pubmed/23762318 http://dx.doi.org/10.1371/journal.pone.0065208 Text en © 2013 Xu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Xu, Qian
He, Cai-yun
Liu, Jing-wei
Yuan, Yuan
Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis
title Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis
title_full Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis
title_fullStr Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis
title_full_unstemmed Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis
title_short Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis
title_sort pre-mir-27a rs895819a/g polymorphisms in cancer: a meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676439/
https://www.ncbi.nlm.nih.gov/pubmed/23762318
http://dx.doi.org/10.1371/journal.pone.0065208
work_keys_str_mv AT xuqian premir27ars895819agpolymorphismsincancerametaanalysis
AT hecaiyun premir27ars895819agpolymorphismsincancerametaanalysis
AT liujingwei premir27ars895819agpolymorphismsincancerametaanalysis
AT yuanyuan premir27ars895819agpolymorphismsincancerametaanalysis